Earlier this year, the Department of Defense classified the schedule of flight tests of ballistic missile defense systems, even though such information had previously been unclassified and publicly disclosed.
Rejecting that move, Congress has now told the Pentagon’s Missile Defense Agency that the flight test schedule must be unclassified.
A new provision in the FY2019 national defense authorization act (sect. 1681) would “require that MDA make the quarter and fiscal year for execution of planned flight tests unclassified.”
“Together with the release of each integrated master test plan of the Missile Defense Agency, and at the same time as each budget of the President is submitted to Congress…, the Director of the Missile Defense Agency shall make publicly available a version of each such plan that identifies the fiscal year and the fiscal quarter in which events under the plan will occur,” the provision states.
This legislative action will effectively override the classification judgment of the executive branch. That is something that Congress rarely does and that the executive branch regards as an infringement on its authority.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
As the efficacy of environmental laws has waned, so has their durability. What was once a broadly shared goal – protecting Americans from environmental harm – is now a political football, with rules that whipsaw back and forth depending on who’s in charge.
It takes the average person over 9 hours and costs $160 to file taxes each year. IRS Direct File meant it didn’t have to.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.